Algen Biotechnologies is building a CRISPR-based screening platform to decode functional gene networks of complex diseases and accelerate cancer therapeutics discovery. Our platform allows for the construction of high-resolution disease maps and identification of novel drugs that selectively reverse cancer signaling while minimizing adverse events in healthy cells and tissue.
Location: United States, California, San Francisco
Employees: 1-10
Investors 4
| Date | Name | Website |
| - | Endless Fr... | endlessfro... |
| - | Rebel Fund | rebelfund.... |
| 16.09.2022 | Draper Ass... | draper.vc |
| 29.06.2022 | Cota Capit... | cotacapita... |
Mentions in press and media 2
| Date | Title | Description |
| 09.10.2025 | Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery | NORWALK, Conn., Oct. 9, 2025 /PRNewswire/ -- Lifespan Vision Ventures congratulates its portfolio company, Algen Biotechnologies, on the announcement of its multi-target research collaboration with AstraZeneca to advance AI-powered drug dis... |
| 31.08.2021 | Here are all the companies from Y Combinator’s Summer 2021 Demo Day, Part 1 | Today Y Combinator kicked off the Demo Day cycle for its Summer 2021 cohort. The collection of early-stage startups on day one-of-two alone numbered in the hundreds, meaning that we had to assemble a team here at TechCrunch just to cover it... |